mifepristone has been researched along with oxidopamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Pruett, SB; Wu, WJ | 1 |
| Felten, DL; Kruszewska, B; Moynihan, JA; Stevens, SY | 1 |
| DeKeyser, FG; Leker, RR; Weidenfeld, J | 1 |
| Bonneau, RH; Leo, NA | 1 |
| Callahan, T; Kruszewska, B; Madden, K; Moynihan, J | 1 |
| Bähr, M; Kügler, S; Maddalena, A; Tereshchenko, J | 1 |
| Bähr, M; Cheng, S; Déglon, N; Konstantinova, P; Kügler, S; Liefhebber, J; Mazur, A; Pythoud, C; Raina, A; Rey, M; Streit, F; Tereshchenko, J; Vachey, G; Zimmer, V | 1 |
8 other study(ies) available for mifepristone and oxidopamine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Suppression of splenic natural killer cell activity in a mouse model for binge drinking. II. Role of the neuroendocrine system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Animals; Azides; Benzodiazepines; Carbolines; Catecholamines; Corticosterone; Diazepam; Disease Models, Animal; Female; GABA-A Receptor Agonists; Glucocorticoids; Immunity, Cellular; Immunity, Innate; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mifepristone; Nadolol; Naltrexone; Neurosecretory Systems; Oxidopamine; Phentolamine; Picrotoxin; Propranolol; Receptors, GABA-A; Spleen; Sympathetic Nervous System | 1996 |
Sympathectomy-induced immune changes are not abrogated by the glucocorticoid receptor blocker RU-486.
Topics: Animals; Cell Division; Corticosterone; Hemocyanins; Hormone Antagonists; Immune System; Immunization; Interferon-gamma; Interleukin-2; Interleukin-4; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mifepristone; Norepinephrine; Oxidopamine; Receptors, Glucocorticoid; Spleen; Sympathectomy; Sympatholytics; Sympathomimetics | 1998 |
Activation of the adrenocortical axis by surgical stress: involvement of central norepinephrine and interleukin-1.
Topics: Adrenocorticotropic Hormone; Animals; Corticosterone; Corticotropin-Releasing Hormone; Craniotomy; Hormone Antagonists; Hypothalamo-Hypophyseal System; Injections, Intraventricular; Injections, Subcutaneous; Interleukin-1; Laparotomy; Male; Median Eminence; Mifepristone; Norepinephrine; Oxidopamine; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Rats; Stress, Physiological | 2000 |
Mechanisms underlying chemical sympathectomy-induced suppression of herpes simplex virus-specific cytotoxic T lymphocyte activation and function.
Topics: Animals; Cell Line; Corticosterone; Herpes Simplex; Herpesvirus 1, Human; Hormone Antagonists; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mifepristone; Neuroimmunomodulation; Norepinephrine; Oxidopamine; Receptors, Mineralocorticoid; Receptors, Steroid; Spleen; Sympathectomy, Chemical; Sympatholytics; T-Lymphocytes, Cytotoxic | 2000 |
Sympathetic nervous system regulation of immunity.
Topics: Analysis of Variance; Animals; Antigen-Presenting Cells; Cells, Cultured; Concanavalin A; Drug Interactions; Hemocyanins; Hormone Antagonists; Immunity; Interleukin-2; Mice; Mifepristone; Oxidopamine; Sympathetic Nervous System; Sympatholytics; T-Lymphocytes | 2004 |
Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease.
Topics: Adenoviridae; Analysis of Variance; Animals; Disease Models, Animal; Dopamine; Functional Laterality; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Hormone Antagonists; Mifepristone; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rotation; Sympatholytics; Time Factors; Vesicular Monoamine Transport Proteins | 2014 |
Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free "GeneSwitch" vector.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Disease Models, Animal; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Green Fluorescent Proteins; Homovanillic Acid; Hormone Antagonists; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Mifepristone; Oxidopamine; Parkinson Disease; Synapsins; Synucleins; Transduction, Genetic | 2018 |